![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/29/2890257/0/en/Cardiff-Oncology-to-Present-at-the-Jefferies-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/13/2880865/0/en/Cardiff-Oncology-to-Present-at-Upcoming-Investor-Conferences-in-May.html
https://www.globenewswire.com/news-release/2024/05/02/2874671/0/en/Cardiff-Oncology-Reports-First-Quarter-2024-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/25/2870040/0/en/Cardiff-Oncology-to-Report-First-Quarter-2024-Results-and-Provide-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/08/2859566/0/en/Cardiff-Oncology-Presents-Novel-Preclinical-Data-at-AACR-Annual-Meeting-2024-that-Supports-Ongoing-First-line-RAS-mutated-mCRC-Clinical-Study.html
https://www.globenewswire.com//news-release/2024/03/06/2841775/0/en/Cardiff-Oncology-Announces-Upcoming-Presentations-at-the-AACR-Annual-Meeting-2024.html
https://endpts.com/cardiff-teases-plk1-inhibitor-efficacy-in-colorectal-cancer-ahead-of-first-line-readout/
https://www.globenewswire.com//news-release/2024/02/29/2838411/0/en/Cardiff-Oncology-Reports-Fourth-Quarter-and-Full-Year-2023-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/29/2838410/0/en/Cardiff-Oncology-Provides-Clinical-Update-on-Phase-2-Randomized-Second-line-ONSEMBLE-Trial-in-Patients-with-RAS-mutated-mCRC.html
https://www.globenewswire.com//news-release/2024/02/29/2838389/0/en/Cardiff-Oncology-Announces-First-Patient-Dosed-in-Randomized-First-line-RAS-mutated-Metastatic-Colorectal-Cancer-Trial-CRDF-004.html